SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer

NCT01086254 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer Stage IV

Interventions

DRUG: Iniparib
DRUG: gemcitabine
DRUG: cisplatin

Sponsor

Sanofi